106 results
DRSLTR
GMDAQ
Gamida Cell Ltd
3 Jul 18
Correspondence regarding draft registration statement
12:00am
that the Company enters into an agreement with Miltenyi Biotech GmbH, it will assess whether the nature and terms of the agreement require it to be filed pursuant … 31, 2017 using the Income Approach. Please disclose the nature of the material assumptions involved. For example, disclose that this method involves
UPLOAD
GMDAQ
Gamida Cell Ltd
27 Jun 18
Letter from SEC
12:00am
. We note that you determined your ordinary share value as of December 31,
2017
using the Income Approach. Please disclose the nature … , engraftment failures, or death were observed
in these
trials, please revise to describe their nature and prevalence. We note
in that regard
F-1
EX-10.3
GMDAQ
Gamida Cell Ltd
28 Sep 18
Registration statement (foreign)
4:29pm
, the Grantee’s remuneration for services rendered to the Company and the nature and duration of the services rendered by the Grantee to the Company.
No member … nature in connection with the Company’s business and/or within the framework of the services rendered by him to the Company, then all such purchased
10-K
EX-10.19
a8na igo4tio9n8xaoop
24 Mar 22
Annual report
7:30am
UPLOAD
dvz9 t13b0q2zy7
17 Jul 18
Letter from SEC
12:00am
10-K
EX-10.1
sfzbrl
24 Mar 22
Annual report
7:30am
F-1/A
EX-10.1
mgm79
17 Oct 18
Registration statement (foreign) (amended)
6:06am
CORRESP
zdy67kgcrg0qu
28 Sep 18
Correspondence with SEC
12:00am
NT 10-Q
k9sjxobk8kwtt
16 May 24
Notice of late quarterly filing
4:01pm
6-K
EX-10.1
8u3riogfl5t ipraxy
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
F-1
EX-10.10
srhut87
28 Sep 18
Registration statement (foreign)
4:29pm
F-1
EX-10.14
r3af7yv1
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.8
idabkrj
28 Sep 18
Registration statement (foreign)
4:29pm
CORRESP
8c253r1pc1xa
9 Oct 18
Correspondence with SEC
12:00am